
    
      This protocol is an open-label, single-arm, multisite protocol to provide IV ribavirin
      treatment to patients with probable or suspected case of HFRS. Individuals with a tentative
      diagnosis of HFRS will be admitted to the MTF and treated for up to 7 days with doses of IV
      ribavirin.
    
  